Skip to main navigation
Skip to search
Skip to main content
Sort by
Biochemistry, Genetics and Molecular Biology
Coronary Artery Disease
100%
Exome Sequencing
61%
Allele
56%
Genetics
55%
Blood Plasma
49%
Rare Variant
49%
Cholesterol
48%
Exome
48%
Genomics
45%
Genome-Wide Association Study
42%
Single-Nucleotide Polymorphism
38%
Whole Genome Sequencing
35%
Deficiency
33%
Human Genetics
32%
Angiopoietin
31%
Low-Density Lipoprotein
31%
Lipid
31%
Blood Lipids
29%
Lipoprotein
29%
Hypercholesterolemia
29%
Genetic Divergence
26%
Triglyceride
25%
Genotyping
23%
Loss of Function Mutation
22%
Genome Sequencing
22%
Human Genome
20%
Autosomal Dominant Inheritance
20%
DNA Sequence
20%
HDL-Cholesterol
19%
Haplotype
18%
Lysyl Oxidase
18%
Macrophage
17%
Platelet
17%
Maturity Onset Diabetes of the Young
16%
Genetic Risk
16%
Chromosome
16%
Familial Hypercholesterolemia
15%
Quantitative Trait
15%
Single Nucleotide Polymorphism
15%
Genetic Variation
15%
Wide Association Study
13%
LDL Receptor
13%
Leucine
13%
Coding Region
13%
Proteomics
13%
RNA Sequence
12%
Candidate Gene
12%
Mechanistic Target of Rapamycin
12%
Genetic Architecture
12%
Mitochondrial Genome
12%
Keyphrases
Coronary Artery Disease
84%
Exome Sequencing
60%
SVEP1
55%
Gain-of-function mutation
49%
Coronary Heart Disease
45%
Genome-wide Association Study
36%
Angiopoietin-like
35%
Human Genetics
33%
Rare Variants
32%
Single nucleotide Polymorphism
30%
Low-density Lipoprotein Cholesterol (LDL-C)
28%
Cardiovascular Disease
27%
Human Genome
25%
Whole Genome Sequencing
24%
Macrophages
24%
Polygenic Risk Score
23%
Human Disease
22%
Genetic Disease
21%
Vascular Smooth muscle Cells
21%
Cardiovascular Risk
20%
Coronary Heart Disease Risk
20%
Exome
19%
Odds Ratio
18%
Myocardial Infarction
18%
Autosomal Dominant Hypercholesterolemia
18%
Metabolic Traits
18%
Lysyl Oxidase
18%
Rare Variant Association Study
18%
Triglycerides
18%
Cardiometabolic Disease
17%
Lipoproteins
17%
Type 2 Diabetes Mellitus (T2DM)
17%
Coronary Disease
17%
Plasma Lipids
16%
Protein-coding Genes
16%
Coding Variants
16%
Homozygous Familial Hypercholesterolemia (HoFH)
16%
Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9)
16%
DNA Sequencing
16%
Therapeutic Target
16%
Genotype
15%
Disease Risk
15%
Genetic Risk
15%
LDL Cholesterol
15%
Finns
15%
Heart Failure
15%
95% Confidence Interval
15%
High-density Lipoprotein Cholesterol (HDL-C)
14%
Cardiometabolic
14%
Meta-analysis
14%